References
- ARTURSSON, P. and KARLSSON, J., 1991, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications, 175, 880–885.
- BUNDGAARD, H., 1985, Design of Prodrugs (Amsterdam: Elsevier).
- BUNDGAARD, H., FLACH, E., LARSEN, C. and MIKKELSON, T. J., 1986a, Pilocarpine prodrugs I. synthesis, physicochemical properties and kinetics of lactonization of pilocarpine acid esters. Journal of Pharmaceutical Sciences, 75, 36–43.
- BUNDGAARD, H., FLACH, E., LARSEN, C., MOSHER, G. L. and MIKKELSON, T. J., 1986b, Pilocarpine prodrugs II. synthesis, stability, bioconversion and physicochemical properties of sequentially labile pilocarpine acid diesters. Journal of Pharmaceutical Sciences, 75, 775–783.
- DAS, J. and KIMBALL, S. D., 1995, Thrombin active site inhibitors. Bioorganic and Medical Chemistry, 3, 999–1007.
- HAUPTMANN, J., 2002, Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs. A review of small molecule thrombin inhibitors. European Journal of Clinical Pharmacology, 57, 751–758.
- HAUPTMANN, J. and STURZEBECHER, J., 1999, Synthetic inhibitors of thrombin and Factor Xa: from bench to bedside. Thrombosis Research, 93, 203–241.
- HIDALGO, I. J., RAUB, T. J. and BORCHART, R. T., 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749.
- HOUSTON, J. B., HUMPHREY, M. J., MATTHEW, D. E. and TARBIT, M. H., 1988, Comparison of two azole antifungal drugs, ketoconazole and fiuconazole, as modifiers of rat hepatic monooxygenase activity. Biochemical Pharmacology, 37, 401–408.
- JOHNSON, C. D., LANE, S., EDWARDS, P. N. and TAYLOR, P. J., 1988, Prodrugs based on masked lactones. cyclization based on a-hydroxy amides. Journal of Organic Chemistry, 53, 5130–5139.
- KIM, K. S., MOQUIN, R. V., QIAN, L., MORRISON, R. A., SEILER, S. M., ROBERTS, D. G. M., OGLETREE, M. L., YOUSSEF, S. and CHONG, S., 1996, Preparation of argatroban analog thrombin inhibitors with reduced basic guanidine moiety, and studies of their cell permeability and antithrombotic activities. Medicinal Chemistry Research, 377–383.
- KIMBALL, S. D., 1995, Challenges in the development of orally bioavailable thrombin active site inhibitors. Blood and Coagulation Fibrinolysis, 6, 511–519.
- KROGSGAARD-LARSEN, P. and BUNDGAARD, H., 1991, A Textbook of Drug Design and Development (Philadelphia: Harwood Academic), pp. 113–192.
- LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
- MAURICE, M., PICHARD, L., DAUJAT, M., FABRE, I., JoyEux, J., DOMERGUE, J. and MAUREL, P., 1992, Effects of imidazole derivatives on cytochrome P450 from human hepatocytes in primary culture. FASEB Journal, 6, 752–758.
- NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
- RAUCY, J. and LASKER, J., 1991, Isolation of P450 enzymes from human liver. Methods in Enzymology, 206, 577–587.
- REWINKEL, J. B. M. and ADANG, A. E. P., 1999, Strategies and progress towards the ideal orally active thrombin inhibitor. Current Pharmaceutical Design, 5, 1043–1075.
- SHAN, D., NICOLAOU, M. G., BORCHART, R. T. and WANG, B., 1997, Prodrug strategies based on intramolecular cyclization reactions. Journal of Pharmaceutical Sciences, 86, 765–767.